CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q/A Report 10-Q/A
- 4 Open-market buy Director bought 7,500 shares at $17.48 ($131,100)
- 4 Open-market buy Director bought 8,500 shares at an average $17.31 ($147,150)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- 4 Grant or award Director acquired 5,250 shares (grant or award)
Page 25 of 28 · 542 filings